Market Cap (In USD)
1.49 Million
Revenue (In USD)
-
Net Income (In USD)
-42.21 Thousand
Avg. Volume
7455.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.01-0.1
- PE
- -
- EPS
- -
- Beta Value
- 0.589
- ISIN
- US12651E1064
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ryan Khouri
- Employee Count
- -
- Website
- https://www.cttpharmaceuticals.com
- Ipo Date
- 1997-04-21
- Details
- CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film forming agent. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. The company is based in Ottawa, Canada.
More Stocks
-
NP5
-
EAX
-
MEEMe Today Limited
MEE
-
EKI
-
SOMMY
-
DGIK
-
BNZIW
-
KABRAEXTRUKabra Extrusiontechnik Limited
KABRAEXTRU